FI953866A0 - Indolin-2-johdannaisia - Google Patents

Indolin-2-johdannaisia

Info

Publication number
FI953866A0
FI953866A0 FI953866A FI953866A FI953866A0 FI 953866 A0 FI953866 A0 FI 953866A0 FI 953866 A FI953866 A FI 953866A FI 953866 A FI953866 A FI 953866A FI 953866 A0 FI953866 A0 FI 953866A0
Authority
FI
Finland
Prior art keywords
lower alkyl
heterocycle
aryl
acyl
treatment
Prior art date
Application number
FI953866A
Other languages
English (en)
Swedish (sv)
Other versions
FI112652B (fi
FI953866A (fi
Inventor
Toru Esaki
Takashi Emura
Eiichi Hoshino
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI953866A0 publication Critical patent/FI953866A0/fi
Publication of FI953866A publication Critical patent/FI953866A/fi
Application granted granted Critical
Publication of FI112652B publication Critical patent/FI112652B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI953866A 1993-02-17 1995-08-16 Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi FI112652B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP6729793 1993-02-17
JP6729793 1993-02-17
JP16726293 1993-05-31
JP16726293 1993-05-31
PCT/JP1994/000235 WO1994019322A1 (en) 1993-02-17 1994-02-17 Indolin-2-one derivative
JP9400235 1994-02-17

Publications (3)

Publication Number Publication Date
FI953866A0 true FI953866A0 (fi) 1995-08-16
FI953866A FI953866A (fi) 1995-08-16
FI112652B FI112652B (fi) 2003-12-31

Family

ID=26408486

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953866A FI112652B (fi) 1993-02-17 1995-08-16 Menetelmä uusien terapeuttisesti käyttökelpoisten indolin-2-onijohdannaisten valmistamiseksi

Country Status (19)

Country Link
US (5) US5952511A (fi)
EP (1) EP0685463B1 (fi)
JP (1) JP3419539B2 (fi)
KR (1) KR100226310B1 (fi)
CN (1) CN1046268C (fi)
AT (1) ATE217864T1 (fi)
AU (1) AU6044894A (fi)
CA (1) CA2156287C (fi)
CZ (1) CZ290504B6 (fi)
DE (1) DE69430664T2 (fi)
ES (1) ES2176236T3 (fi)
FI (1) FI112652B (fi)
HU (1) HUT74105A (fi)
MY (1) MY128102A (fi)
NO (1) NO305201B1 (fi)
PL (1) PL176710B1 (fi)
RU (1) RU2128170C1 (fi)
TW (1) TW281669B (fi)
WO (1) WO1994019322A1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878728B1 (en) 1999-06-11 2005-04-12 Vertex Pharmaceutical Incorporated Inhibitors of aspartyl protease
US20040122000A1 (en) 1981-01-07 2004-06-24 Vertex Pharmaceuticals Incorporated. Inhibitors of aspartyl protease
US5723490A (en) * 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
US5783701A (en) * 1992-09-08 1998-07-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
IS2334B (is) * 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
PT731091E (pt) * 1993-11-26 2002-05-31 Tanabe Seiyaku Co Derivados de 2-oxoindolina como antagonistas do receptor de colecistoquinina
AU699483B2 (en) * 1994-03-07 1998-12-03 Vertex Pharmaceuticals Incorporated Sulphonamide derivatives as aspartyl protease inhibitors
US5691372A (en) * 1995-04-19 1997-11-25 Vertex Pharmaceuticals Incorporated Oxygenated-Heterocycle containing sulfonamide inhibitors of aspartyl protease
US6004957A (en) * 1995-06-07 1999-12-21 Vertex Pharmaceuticals, Incorporated Sulfonamide inhibitors of aspartyl protease
WO1997033867A1 (fr) * 1996-03-11 1997-09-18 Ube Industries, Ltd. Procede de preparation de composes d'indole actifs sur le plan optique
WO1998002419A1 (fr) * 1996-07-12 1998-01-22 Chugai Seiyaku Kabushiki Kaisha Inhibiteurs de proliferation de cellules cancereuses
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
BR9912169A (pt) 1998-06-19 2001-04-10 Vertex Pharma Inibidores de sulfonamida de protease de aspartil
AU1648600A (en) * 1998-12-04 2000-06-26 Neurosearch A/S Use of isatin derivatives as ion channel activating agents
US6605623B1 (en) 1998-12-18 2003-08-12 Bristol-Myers Squibb Pharma Co. N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
ATE283840T1 (de) * 1999-01-29 2004-12-15 Chugai Pharmaceutical Co Ltd Chondrogonese promotoren und indolin-2-on derivate
EP1175399B1 (en) * 1999-04-23 2009-03-11 Vertex Pharmaceuticals Incorporated Inhibitors of c-jun n-terminal kinases (jnk)
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
KR101026205B1 (ko) * 1999-11-23 2011-03-31 메틸진 인코포레이티드 히스톤 디아세틸라제의 억제제
US20030187054A1 (en) * 2000-03-10 2003-10-02 Shunsuke Nagao Preparations for chondrogenesis
US7612065B2 (en) 2000-04-21 2009-11-03 Vertex Pharmaceuticals Incorporated Inhibitors of c-JUN N-terminal kinases (JNK)
AU2001271357A1 (en) * 2000-06-21 2002-01-02 Dupont Pharmaceuticals Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
US6638950B2 (en) 2000-06-21 2003-10-28 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
AU2003299227A1 (en) * 2002-12-20 2004-07-14 Ciba Specialty Chemicals Holding Inc. Synthesis of amines and intermediates for the synthesis thereof
CN1324009C (zh) * 2003-01-30 2007-07-04 普文英 化合物1-n-甲氧基-2-氧-吲哚-3-乙酰胺及其药物用途
US20080030974A1 (en) * 2006-08-02 2008-02-07 Abu-Ageel Nayef M LED-Based Illumination System
US20090050905A1 (en) * 2007-08-20 2009-02-26 Abu-Ageel Nayef M Highly Efficient Light-Emitting Diode
US20100202129A1 (en) * 2009-01-21 2010-08-12 Abu-Ageel Nayef M Illumination system utilizing wavelength conversion materials and light recycling
US8987310B2 (en) 2009-10-30 2015-03-24 Merck Sharp & Dohme Corp. Heterocycle amide T-type calcium channel antagonists
CN102516153B (zh) * 2011-12-14 2014-03-12 南京工业大学 5-氟吲哚-2-酮-3-脲类化合物及其制备方法和应用
BR112016011727A2 (pt) 2013-11-22 2017-08-08 CL BioSciences LLC Antagonistas de gastrina para o tratamento e prevenção de osteoporose
KR102161674B1 (ko) * 2014-02-18 2020-10-05 주식회사 대웅제약 이사틴 유도체 및 이의 제조방법
CN113456631B (zh) * 2021-08-06 2022-06-21 徐州医科大学 一种靶向acsl1的小分子药物及其在治疗子宫内膜癌中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
JPS62234080A (ja) * 1985-12-20 1987-10-14 Kissei Pharmaceut Co Ltd インドリン−2−オン誘導体
JPS62228072A (ja) * 1985-12-20 1987-10-06 Kissei Pharmaceut Co Ltd 3−アミノインドリン−2−オン誘導体
US4760083A (en) * 1986-04-10 1988-07-26 E. I. Dupont De Nemours & Company 3,3-disubstituted indolines
JPS62270576A (ja) * 1986-05-19 1987-11-24 Kissei Pharmaceut Co Ltd イサチン誘導体
JPS63156771A (ja) * 1986-12-19 1988-06-29 Kissei Pharmaceut Co Ltd 3−アミノインドリン−2−オン誘導体
JPS62156771A (ja) * 1986-12-19 1987-07-11 Tokyo Shokai:Kk 処方箋処理装置
US4876259A (en) * 1987-01-05 1989-10-24 E. I. Du Pont De Nemours And Company 3,3-disubstituted indolines
JPH03503650A (ja) * 1988-04-05 1991-08-15 アボツト・ラボラトリーズ Cckアンタゴニストとしてのトリプトファン誘導体
ATE208400T1 (de) * 1990-08-31 2001-11-15 Warner Lambert Co Pro-medikamente für cck-antagonisten
WO1992007830A2 (en) * 1990-10-29 1992-05-14 Pfizer Inc. Oxindole peptide antagonists
CA2055094A1 (en) * 1990-11-13 1992-05-14 Mark G. Bock Cholecystokinin antagonist
JPH05104510A (ja) * 1991-10-18 1993-04-27 Inax Corp 基板へのモルタル塗布方法

Also Published As

Publication number Publication date
CZ290504B6 (cs) 2002-08-14
US6127544A (en) 2000-10-03
CN1046268C (zh) 1999-11-10
FI112652B (fi) 2003-12-31
TW281669B (fi) 1996-07-21
CZ209695A3 (en) 1995-12-13
CA2156287A1 (en) 1994-09-01
JPH0748349A (ja) 1995-02-21
WO1994019322A1 (en) 1994-09-01
NO305201B1 (no) 1999-04-19
KR960701011A (ko) 1996-02-24
CA2156287C (en) 2005-12-27
HUT74105A (en) 1996-11-28
MY128102A (en) 2007-01-31
DE69430664D1 (de) 2002-06-27
JP3419539B2 (ja) 2003-06-23
PL310168A1 (en) 1995-11-27
CN1117727A (zh) 1996-02-28
NO953235D0 (no) 1995-08-17
US6031111A (en) 2000-02-29
DE69430664T2 (de) 2003-01-30
AU6044894A (en) 1994-09-14
NO953235L (no) 1995-10-09
EP0685463B1 (en) 2002-05-22
KR100226310B1 (ko) 1999-10-15
ES2176236T3 (es) 2002-12-01
FI953866A (fi) 1995-08-16
RU2128170C1 (ru) 1999-03-27
EP0685463A1 (en) 1995-12-06
US5952511A (en) 1999-09-14
US6207836B1 (en) 2001-03-27
HU9502415D0 (en) 1996-05-28
US6114536A (en) 2000-09-05
ATE217864T1 (de) 2002-06-15
PL176710B1 (pl) 1999-07-30
EP0685463A4 (fi) 1996-01-03

Similar Documents

Publication Publication Date Title
FI953866A0 (fi) Indolin-2-johdannaisia
PE20051056A1 (es) Compuestos de 1-(azolin-2-il)amino-1,2-difeniletano para combatir insectos, aracnidos y nematodos
CY1113118T1 (el) Παραγωγα πυριμιδινης
DE69413019D1 (de) Stickstoff enthaltende kondensierte heterocylen
MX9304735A (es) Compuestos.
ES2121183T3 (es) Ligandos selectivos de los receptores 5ht1d-5ht1b derivados de indol-piperacina utiles como medicamentos.
NO995289D0 (no) Benzimidazol-derivater
BG101000A (en) Formulaminophenylsulphonyl ureas, methods of oreparing them and their use as herbicides and plant-growth regulators
TR199903249T2 (xx) �l-5 inhibit�rleri olarak 6-Azaurasil t�revleri.
BR9506763A (pt) Derivados de carbamoil metil uréia
ATE47841T1 (de) 5-sulfonamido-1-aryl-pyrazole.
TH17368EX (th) อนุพันธ์ของอินโดลิน-2-โอน
TH17368A (th) อนุพันธ์ของอินโดลิน-2-โอน